Background: Association studies in the Turkish population have investigated the single locus effects of different gene polymorphisms on coronary artery disease (CAD). CAD is a complex polygenic disease that involves complex interactions among multiple genetic and environmental conditions.
Design: We evaluated associations of five candidate genetic polymorphisms (methylene tetrahydrofolate reductase C677T, plasminogen activator inhibitor 4G/5G, endothelial nitric oxide synthase (eNOS) 3–27 base pair repeat, insertion, or deletion of a 287 bp Alu repeat sequence polymorhism of angiotensin I converting enzyme, and paraoxonase Gln192Arg PON1 polymorphisms) with the presence and extent of early onset CAD.
Methods: DNA was isolated and amplified from 90 consecutive patients with angiographically proven early onset CAD (ages 41 ± 5 for men, 49 ± 7 for women) and also from 90 control subjects with no significant coronary obstruction angiographically (ages 42 ± 5 for men, 48 ± 6 for women). Multifactor dimensionality reduction (MDR) analysis was performed to identify a model of CAD based on both genetic and conventional risk factors.
Results: MDR analysis detected a significant model with four genes (prediction success ∼ 61%, p = 0.03). When the total number of the conventional risk factors is analysed with the candidate polymorphisms, a different model is identified that includes three of the four genes from the above model and achieves a similar prediction of CAD as the gene only model.
Conclusion: These data indicate that gene–gene and gene–environmental risk interactions form significant models in predicting early onset CAD.
AndersonJLCarlquistJFHorneBDHopkinsPN. Progress in unraveling the genetics of coronary artery disease and myocardial infarction. Curr Atheroscler Rep2007; 9(3): 179–186.
2.
HamstenAErikssonP. Identifying the susceptibility genes for coronary artery disease: from hyperbole through doubt to cautious optimism. J Intern Med2008; 263(5): 538–552.
3.
ErbsSMöbius-WinklerSLinkeAAdamsVDollNGielenS. Both T786C and G894T polymorphism of endothelial nitric oxide synthase affect in-vitro endothelium-dependent relaxation of internal mammary artery rings from patients with coronary artery disease. Eur J Cardiovasc Prev Rehabil2006; 13(5): 826–831.
4.
RiccioniGBazzanoLA. Antioxidant plasma concentration and supplementation in carotid intima media thickness. Expert Rev Cardiovasc Ther2008; 6(5): 723–729.
5.
MoensALVrintsCJClaeysMJTimmermansJPChampionHCKassDA. Mechanisms and potential therapeutic targets for folic acid in cardiovascular disease. Am J Physiol Heart Circ Physiol2008; 294(5): H1971–H1977.
6.
AgirbasliM. Pivotal role of plasminogen-activator inhibitor 1 in vascular disease. Int J Clin Pract2005; 59(1): 102–106.
7.
RitchieMDHahnLWRoodiNDupontWDPlummerWDPearlFF. Multifactor Dimensionality Reduction reveals high-order interactions among estrogen metabolism genes in sporadic breast cancer. Am J Hum Genet2001; 69(1): 138–147.
8.
TaymazHErarslanSOnerETAlkanTAgirbasliMKirdarB. Sequence variations within the genes related to hemostatic imbalance and their impact on coronary artery disease in Turkish population. Thromb Res2007; 119(1): 55–62.
9.
YilmazHIsbirSAgachanBErgenAFarsakBIsbirT. C677T mutation of methylenetetrahydrofolate reductase gene and serum homocysteine levels in Turkish patients with coronary artery disease. Cell Biochem Funct2006; 24(1): 87–90.
10.
AcarturkEAttilaGBozkurtAAkpinarOMatyarSSeydaogluG. Insertion/deletion polymorphism of the angiotensin converting enzyme gene in coronary artery disease in southern Turkey. J Biochem Mol Biol2005; 38(4): 486–490.
11.
AlpEMenevseSTulmacMKanDYalcinRErkanAF. Lack of association between matrix metalloproteinase-9 and endothelial nitric oxide synthase gene polymorphisms and coronary artery disease in Turkish population. DNA Cell Biol2009; 28: 343–350.
12.
AynaciogluASCascorbiIMrozikiewiczPMNacakMTapanyigitEERootsI. Paraoxonase 1 mutations in a Turkish population. Toxicol Appl Pharmacol1999; 157: 174–177.
13.
Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts)European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Eur J Cardiovasc Prev Rehabil2007; 14(Suppl 2): E1–E40.
14.
Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in AdultsExecutive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA2001; 285: 2486–2497.
15.
MooreJHGilbertJCTsaiCTChiangFTHoldenTBarneyN. A flexible computational framework for detecting, characterizing, and interpreting statistical patterns of epistasis in genetic studies of human disease susceptibility. J Theor Biol2006; 241(2): 252–261.
16.
HahnLWRitchieMDMooreJH. Multifactor dimensionality reduction software for detecting gene–gene and gene–environment interactions. Bioinformatics2003; 19(3): 376–382.
17.
VelezDRWhiteBCMotsingerAABushWSRitchieMDWilliamsSM. A balanced accuracy function for epistasis modeling in imbalanced datasets using multifactor dimensionality reduction. Genet Epidemiol2007; 31(4): 306–315.
18.
WilliamsSMRitchieMDPhillipsJA 3rdIIIDawsonEPrinceMDzhuraE. Multilocus analysis of hypertension: A hierarchical approach. Hum Hered2004; 57(1): 28–38.
19.
WilliamsSMHainesJLMooreJH. The use of animal models in the study of complex disease: all else is never equal or why do so many human studies fail to replicate animal findings?Bioessays2004; 26(2): 170–179.
20.
WilliamsSMAddyJHPhillipsJA3rdDaiMKpodonuJAffulJ. Combinations of variations in multiple genes are associated with hypertension. Hypertension2000; 36(1): 2–6.
21.
MooreJHWilliamsSM. Strategies for identifying gene–gene interactions in hypertension. Ann Med2002; 34: 88–95.
22.
RudnickiMMayerG. Significance of genetic polymorphisms of the renin-angiotensin-aldosterone system in cardiovascular and renal disease. Pharmacogenomics2009; 10(3): 463–476.
23.
VarAUtükOAkçalıSSanlıdağTUyanıkBSDinçG. Impact of hemostatic gene single point mutations in patients with non-diabetic coronary artery disease. Mol Biol Rep2009; 36(8): 2235–2243.
24.
AgirbasliDAgirbasliMWilliamsSMPhillipsJA 3rd. Interaction among 5,10 methylenetetrahydrofolate reductase, plasminogen activator inhibitor and endothelial nitric oxide synthase gene polymorphisms predict the severity of coronary artery disease in Turkish patients. Coron Artery Dis2006; 17(5): 413–417.
